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Abstract
Background: Mitochondria have roles or appear to have roles in the pathogenesis of several chronic age-related
and acute neurological disorders, including Charcot-Marie-Tooth disease, amyotrophic lateral sclerosis, Parkinson’s
disease, and cerebral ischemia, and could be critical targets for development of rational mechanism-based, disease-
modifying therapeutics for treating these disorders effectively. A deeper understanding of neural tissue
mitochondria pathobiologies as definitive mediators of neural injury, disease, and cell death merits further study,
and the development of additional tools to study neural mitochondria will help achieve this unmet need.
Results: We created transgenic mice that express the coral (Discosoma sp.) red fluorescent protein DsRed2
specifically in mitochondria of neurons using a construct engineered with a Thy1 promoter, specific for neuron
expression, to drive expression of a fusion protein of DsRed2 with a mitochondrial targeting sequence. The
biochemical and histological characterization of these mice shows the expression of mitochondrial-targeted
DsRed2 to be specific for mitochondria and concentrated in distinct CNS regions, including cerebral cortex,
hippocampus, thalamus, brainstem, and spinal cord. Red fluorescent mitochondria were visualized in cerebral
cortical and hippocampal pyramidal neurons, ventrobasal thalamic neurons, subthalamic neurons, and spinal motor
neurons. For the purpose of proof of principle application, these mice were used in excitotoxicity paradigms and
double transgenic mice were generated by crossing Thy1-mitoDsRed2 mice with transgenic mice expressing
enhanced-GFP (eGFP) under the control of the Hlxb9 promoter that drives eGFP expression specifically in motor
neurons and by crossing Thy1-mitoDsRed2 mice to amyotrophic lateral sclerosis (ALS) mice expressing human
mutant superoxide dismutase-1.
Conclusions: These novel transgenic mice will be a useful tool for better understanding the biology of
mitochondria in mouse and cellular models of human neurological disorders as exemplified by the mitochondrial
swelling and fission seen in excitotoxicity and mouse ALS.
Keywords: Alzheimer’s disease, amyotrophic lateral sclerosis, CA1 neuron, excitotoxicity, motor neuron, Parkinson’s
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Mitochondria have been implicated in the pathobiology
of several neurological disorders, including Charcot-
Marie-Tooth disease, chronic progressive external
opthalmoplegia, mitochondrial encephalomyopathy lac-
tic acidosis and stroke-like episodes syndrome, and less
directly in stroke, amyotrophic lateral sclerosis (ALS),
Parkinson’sd i s e a s e ,a n dA l z h e i m e r ’s[ 1 - 4 ] .Av a r i e t yo f
pathogenic mechanisms could be directly or indirectly
linked to perturbations in mitochondrial physiology
and signaling [3,4], notably trafficking, fission/fusion,
oxidative stress and reactive oxygen species (ROS)
damage to macromolecules, glutamate receptor excito-
toxicity and intracellular Ca
2+ deregulation, protein
aggregation, and permeability transition pore activation
[5,6]. Mitochondria are producers of toxic ROS that
can damage cellular constituents, including DNA,
RNA, protein, and lipids, and initiate many forms of
cell death in mammalian cells [2,6,7]. Human mutant
proteins linked to Parkinson’sd i s e a s e ,A L S ,a n dA l z -
heimer’s disease can associate with mitochondria in
mouse and cellular models and can cause mitochon-
drial dysfunction [3,6]. Mitochondria are sources of
several apoptogenic proteins that upon release execute
the apoptotic process [6-8]. Release of apoptogenic
proteins from mitochondria can occur through
mechanisms involving formation of membrane chan-
nels comprised of Bax [9], Bax and the adenine nucleo-
tide translocator [10], the voltage dependent anion
channel (VDAC) [11], and the mitochondrial perme-
ability transition pore (mPTP) [7]. Mitochondria med-
iate the apoptotic process in adult brain neurons by
mPTP-triggered ROS and nitric oxide production after
their accumulation and priming instigated by Zn
2+ and
Ca
2+ accumulation [12]. Mitochondrial targeted drugs
such as TRO19662 (olesoxime) and Bcl-XL:BH4 pep-
tides can block apoptosis of neurons within the adult
mouse CNS [12]. Thus, mitochondria are validated
important targets for the design of drugs and small
molecules as neuroprotectants with potential in vivo
CNS efficacy in the treatment of several neurological
disorders [6,12].
The ability to genetically express jellyfish and coral
fluorescent proteins in mammalian cells has revolutio-
nized experimental approaches [13]. Under the control
of specific gene promoters, fluorescence proteins can
serve as reporters for tissues, cells, and organelles, as
well as toxicity biosensors [14-16]. Many transgenic (tg)
mouse lines have been engineered to express green
fluorescent protein (GFP), yellow fluorescent protein
(YFP), red fluorescent protein, or cyan fluorescent pro-
tein in tissues and cells. For example, motor neuron and
neuromuscular junction (NMJ) biology can be studied
using tg mice expressing enhanced-GFP (eGFP) under
the control of the Hlxb9 promoter that drives eGFP
expression specifically in motor neurons and their entire
cell body and peripheral axon to the NMJ [17]. The
NMJ can also be evaluated in tg mice expressing YFP
driven by the neuron-specific promoter thymus cell
antigen 1(Thy1) [18,19]. In these mice, neurons are filled
with YFP to reveal a Golgi stain-like resolution [18].
Interneurons in brain and spinal cord are difficult to
identify with certainty in tissue sections using antibodies
and in living slices and dissociated cell cultures, but in
tg mice expressing eGFP driven by the glutamic acid
decarboxylase gene promoter [20] or the glycine trans-
porter-2 gene promoter [21], GABAergic and glycinergic
interneurons, respectively, can be visualized in exquisite
detail. Here, we describe the generation and characteri-
zation of new tg mice that express the marine coral
(Discosoma sp.) red fluorescent protein DsRed2 specifi-
cally in mitochondria of neurons.
Results
Engineering of the Thy1-mitoDsRed gene construct
The design of the Thy1-mitoDsRed2 expression con-
struct is shown in Figure 1. We cloned the entire frag-
ment of mitoDsRed2 gene into the XhoI site of the
Thy1 promoter by T4 ligation (see Methods). Correct
clones were identified by restriction enzyme digestion
and direct sequencing (data not shown). All sequences
were confirmed by sequencing in both forward and
reverse directions. In addition, cultured cells were trans-
fected with the construct to confirm that the codons are
in-frame as determined by protein expression.
Visualization of mitochondria in living cultured neurons
using mitochondrial-targeted DsRed2
To establish a pattern for recognition of DsRed-labeled
mitochondria in living cells, we used the unmodified
mitoDsRed2 plasmid (Clontech) to transfect mouse pri-
mary cortical neurons and motor neuron-like cells dif-
ferentiated from the NSC34 cell line. Transfected
cortical neurons (Figure 2A) and NSC34 cells (Figure
2 B )s h o w e db r i g h tr e df l u o r e scence as discrete round-,
oval-, and rod-like foci consistent with expectations for
mitochondria and with previous reports [22-24]. DsRed-
labeled mitochondria could be tracked far distances
within the processes of cortical neurons (Figure 2A,
arrows). Large differentiated motor neuron-like cells in
NSC34 cell cultures showed numerous perikaryal mito-
chondria (Figure 2B). Astrocytes in mixed-cell cortical
cultures transfected with mitoDsRed2 also displayed vast
numbers of mitochondria (Figure 2C).
Cell cultures transfected with our Thy1-mitoDsRed
plasmid showed fluorescent labeling in a pattern
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design of the engineered plasmid was correct by direct
demonstration of expressed DsRed protein. Motor neu-
rons differentiated from NSC34 cells showed high
expression of Thy1-mitoDsRed in the cell bodies and far
into distal processes (Figure 2D). Similarly, living pri-
mary spinal cord neurons transfected with Thy1-
mitoDsRed showed fluorescent mitochondria in the cell
body (Figure 2E) and, with longer exposures, in numer-
ous fine distal processes (Figure 2F, G). Transfected
astrocytes were not seen in cortical neuron and spinal
cord neuron cultures transfected with Thy1-mitoDsRed.
To model an insult that would be expected to produce
mitochondrial pathology in neurons, an excitotoxic chal-
lenge was used [24]. Cortical neuron cultures transfected
with Thy1-mitoDsRed and treated with the potent N-
methyl-D-aspartate (NMDA) receptor agonist quinolinic
acid showed swelling of mitochondria and dendritic
attrition (Figure 2I, arrows) in comparison with trans-
fected neurons treated with vehicle (Figure 2H).
Thy1-mitoDsRed2 tg mouse generation and
characterization of tissue-specific expression of DsRed2 in
tg mice using immunoblotting and RT-PCR
We had 5 tg founder mice for Thy1-mitoDsRed 2 iden-
tified by PCR amplification of the DsRed transgene (Fig-
u r e3 A )w h i c hw e r eu s e dt od e v e l o pam o u s ec o l o n y .
Western blotting was used to establish the mitochon-
drial expression of DsRed in brain and spinal cord tissue
fractions. In Thy1-mitoDsRed2 tg mice, DsRed protein
was concentrated in mitochondrial-enriched fractions of
whole brain and spinal cord but was undetectable in
soluble protein fractions of these tissues (Figure 3B). In
brain and spinal cord mitochondria, monomeric DsRed
migrated at ~29 kDa, matching the migration of recom-
binant DsRed (Figure 3B). The DsRed monoclonal anti-
body also detected higher molecular proteins in the
mitochondrial fractions that were not seen in soluble
fractions (Figure 3B), but the identity of these reactive
proteins is unclear. Western blotting for DsRed in crude
tissue extracts of CNS and body organs of Thy1-
mitoDsRed tg mice, compared against recombinant
DsRed, confirmed the nervous tissue-specific expression
of DsRed. In four of five tg mouse lines, DsRed was
detected in cerebral cortex, hippocampus, diencephalon,
brainstem, cerebellum, and spinal cord, but not in kid-
ney and liver (Figure 3C). Other organs evaluated that
were negative for DsRed were heart and skeletal muscle
(data not shown). One of five tg mouse lines showed
low expression of DsRed protein in kidney (data not
shown) in addition to CNS expression. RT-PCR was
used to show mRNA expression specifically in brain tis-
sue. DsRed mRNA was detected robustly in brain but
not in skeletal muscle, heart, liver, and kidney in 4 of 5
lines (Figure 3D). DsRed mRNA expression was further
shown in specific regional microdissections of cerebral
cortex, hippocampus, striatum, diencephalon, brainstem,
and spinal cord (Figure 3E). The brainstem showed the
Figure 1 Design of Thy1-mitoDsRed construct used to generate tg mice. A tg construct containing the entire open reading frame of the
DsRed2 gene (red) fused in frame with the mitochondrial targeting sequence of the human cytochrome c oxidase subunit VIII gene (orange) was
cloned into the Thy1.2 expression cassette at the XhoI site by T4 ligation.
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(Figure 3E).
Neuronal mitochondria visualization in Thy1-mitoDsRed2
tg mouse brain and spinal cord
Thick sections (40 μm) from tg and non-tg littermate
mouse brain and spinal cord were examined for DsRed
fluorescence. Generally, fluorescence for DsRed was
observed highest in cerebral cortex, hippocampus,
striatum, diencephalon, brainstem, and spinal cord but
was very low in regions such as the hypothalamus (Figure
4). Younger mice (< 6 months of age) generally showed
stronger DsRed fluorescence than older mice (> 12
months of age). DsRed fluorescence was much more
obvious in gray matter than in white matter. In somato-
sensory cortex, mid-layers showed extremely bright
DsRed fluorescence (Figure 4A). In the homotypic cortex
of non-tg littermate mice no red fluorescence was seen
Figure 2 Visualization of mitochondria in living cultured neurons using mitochondrial-targeted DsRed2. A. Embryonic mouse primary
cerebral cortical neuron transfected with mitoDsRed plasmid. The cell body (lower left) containing numerous mitochondria is overexposed to
show individual mitochondria in fine distal processes (arrows). Scale bar = 7 μm. B. NSC34 motor neuron-like cells transfected with mitoDsRed
plasmid showing vast numbers of mitochondria forming a network in the cytoplasm surrounding the nucleus (asterisk). Scale bar = 6 μm. C.
Mouse cerebral cortical astrocytes expressing mitochondrial-targeted DsRed show mitochondria as long vermiform, ellipsoid, or round organelles.
Asterisks identify nucleus. Scale bar = 6 μm. D. NSC34-motor neuron transfected with Thy1-mitoDsRed plasmid. Cell body fluorescence is bright
due to numerous mitochondria and overexposure, while individual mitochondria in a long dendrite (arrow) can be discerned. Scale bar = 6 μm.
E-G. Embryonic mouse primary spinal cord neuron transfected with Thy1-mitoDsRed plasmid and shown at different exposures to reveal red
fluorescent mitochondria in the cell body (E, asterisk marks the nucleus) and distal processes (F and G, arrows). Scale bar = 6 μm. H and I.
NMDA receptor activation by quinolinic acid causes mitochondrial pathology as seen directly in living cultured primary cortical neurons by Thy1-
mitoDsRed. Mouse cortical neurons treated with PBS (vehicle) show numerous individual mitochondria distributed throughout the dendritic
arborization (H, arrows). Neurons treated with 100 μM quinolinic acid undergo mitochondrial swelling (arrows) and dendrite retraction by 4
hours (I). Scale bars = 6 μm. Images are representative of at least 3 different cell culture experiments.
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Page 4 of 15(Figure 4B), serving as a negative control. In hippocam-
pus, intense DsRed fluorescence was present in the stra-
tum lacunosum-moleculare of CA1 (Figure 4C), a site of
synaptic termination of entorhinal perforant path fibers
and Schaffer collaterals onto distal dendrites of CA1 pyr-
amidal neurons [25], but, in comparison, the adjacent
dentate gyrus had low DsRed fluorescence (Figure 4C).
Under high magnification, individual CA1 pyramidal
neuron cell bodies contained numerous DsRed-tagged
mitochondria that co-labeled with VDAC immunoreac-
tivity (Figure 4C, inset) or SOD2 immunoreactivity (data
not shown). The thalamus, particularly the ventrobasal
complex, contained numerous neurons expressing DsRed
(Figure 4D, E) and the nearby subthalamic nucleus was
also highly enriched in DsRed (Figure 4E). The spinal
cord gray matter neuropil was brightly fluorescent for
DsRed (Figure 4F). Subsets of individual neurons deep
within the dorsal horn possessed abundant DsRed-
labeled mitochondria, confirmed as mitochondria by
VDAC immunoreactivity (Figure 4G). Ventral horn
motor neurons also contained numerous perikaryal and
dendritic mitochondria that co-labeled with DsRed and
VDAC immunoreactivity. Interestingly, in hippocampal
and spinal cord neurons, not all DsRed-tagged mitochon-
dria were co-labeled with mitochondrial marker immu-
noreactivity and vice versa (Figure 4C inset, G, H).
Immunohistochemistry wasu s e dt oc h a r a c t e r i z e
further the intracellular localization of DsRed in Thy1-
mitoDsRed tg mouse brain sections by immunofluores-
cence (Figure 5). DsRed fluorescence in neurons was
Figure 3 Thy1-mitoDsRed2 tg mouse generation and characterization. A. Genomic identification of tg mice. Thy1-mitoDsRed tg mice
showed a PCR-amplified 208 bp product that was undetected in non-tg mice. B. Western blot analysis of subcellular fractions of Thy1-
mitoDsRed tg mouse brain and spinal cord demonstrating the presence of DsRed protein in mitochondrial-enriched fractions but not in soluble
protein fractions. Purified recombinant DsRed was loaded as a positive control. Blots were reprobed with antibody to cofilin to show protein
loading. Results were replicated using several tg mice (n = 8). C. Western blot analysis showing the tissue distributions and brain regional
distributions of DsRed protein expression in Thy1-mitoDsRed tg mice. Crude extracts were used. DsRed protein was detected at varying levels of
expression in most CNS regions but not in liver or kidney (4 of 5 lines). Recombinant DsRed was loaded as a positive control. The nitrocellulose
membrane was stained with Ponceau S to show protein loading. Results were replicated using several tg mice (n = 8). D. RT-PCR analysis
showing the tissue distributions of DsRed mRNA expression in Thy1-mitoDsRed tg mice. DsRed mRNA was detected in brain but not in skeletal
muscle, heart, liver, or kidney. VDAC1 mRNA was used as an internal control. Results were replicated using several tg mice (n = 5). E. RT-PCR
analysis showing brain regional distributions of DsRed mRNA expression in Thy1-mitoDsRed tg mice. DsRed protein was detected at varying
levels of expression in several different CNS regions. VDAC1 mRNA was an internal control. Results were replicated using several tg mice (n = 5).
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Page 5 of 15Figure 4 Mitochondrial visualization in Thy1-mitoDsRed2 tg mouse CNS. A. Tg mice showed DsRed fluorescence in somatosensory cortex
with varying intensities in different cortical layers. Scale bar = 70 μm (same for B). B. Non-tg mice have no red fluorescence in somatosensory
cortex. C. Tg mice showed DsRed fluorescence in hippocampus. All layers of CA1 were fluorescent, including stratum oriens (so), stratum
pyramidale (sp), stratum radiatum (sr), and stratum lacunosum-moleculare (sl), with the sl showing the highest intensity; the dentate gyrus (DG)
showed lower DsRed fluorescence compared to CA1. The granule cell layer of DG was nearly negative. Inset shows colocalization (orange-
yellow) of DsRed fluorescence with VDAC (green) in a CA1 pyramidal neuron cell body. Nuclei are blue. Scale bars = 47 μm (inset, 4 μm). D.T g
mice showed DsRed fluorescence in ventrobasal complex of thalamus. Scale bar = 70 μm. E. Tg mice showed DsRed fluorescence in
subthalamic nucleus, while nearby cerebral peduncle and lateral hypothalamus showed very low fluorescence. Scale bar = 70 μm. F. Spinal cord
gray matter showed DsRed fluorescence in tg mice. White hatched boxes in dorsal horn and ventral delineate regions shown at higher
magnification in G and H. Scale bar = 100 μm. G. Colocalization (orange-yellow) of DsRed fluorescence with VDAC (green) in dorsal horn
neurons. Cell nuclei are blue. Scale bar = 5 μm. H. Colocalization (orange-yellow, arrows) of DsRed fluorescence with VDAC (green) in motor
neuron. Scale bar = 3 μm. Images are representative of numerous tg (n = 20) or control (n = 10) mice.
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Page 6 of 15segregated from the peroxisome compartment and
nucleus as demonstrated by localizations distinct from
catalase (Figure 5A). Interestingly, DsRed did show
some colocalization with the autophagy marker LC3A
(Figure 5B), possibly reflecting mitophagy. In contrast,
intracellular DsRed was completely distinct from the
smooth endoplasmic reticulum (ER) compartment, as
indicated by the lack of overlap with cytochrome P450
reductase (Figure 5C).
Thy1-mitoDsRed2 tg mice display no overt neurological
abnormalities or neuropathology
Thy1-mitoDsRed tg mice are healthy and fertile. They
have a normal lifespan of > 24 months. They show no
overt evidence of seizure abnormalities or movement
disorders. Brain and spinal cord sections examined
using Nissl and silver staining, as well as immunofluor-
escent staining for cleaved caspase-3, showed no evi-
dence for neurodegeneration (data not shown).
Applications of Thy1-mitoDsRed2 tg mice in studies of
motor neurons
To demonstrate the utility of these novel tg mice, they
were used in studies of motor neurons. One application
was for cell culture and other uses were in vivo. For
motor neuron cell culture studies, mitochondrial track-
ing with Thy1-DsRed expression was combined with
whole-cell eGFP labeling. We used tg mice expressing
eGFP driven by the Hb9 promoter [17] to identify
motor neurons. In spinal cord sections of E12-14
embryos of Hb9-eGFP mice, numerous cells throughout
ventral spinal cord express eGFP (Figure 6A). The iden-
tification of large-size (> 28 μm) and medium-size (15-
28 μm) Hb9-eGFP cells as motor neurons in dissociated
spinal cord culture has been confirmed [26,27]. Here,
flow cytometry and fluorescence-activated cell sorting
(FACS) was used to sort eGFP-expressing motor neu-
rons (Figure 6B, C) for subsequent culture (Figure 6D)
and transfection with Thy1-mitoDsRed expression con-
struct to identify mitochondria specifically in living
motor neurons (Figure 6F). Another experimental
approach was to cross Thy1-mitoDsRed tg mice and
Hb9-eGPF tg mice to generate fluorescent protein dou-
ble tg mouse embryos to directly visualize mitochondria
in cultured neurons unequivocally identifiable as motor
neurons (Figure 6G, H).
We also crossed tg mice expressing mitoDsRed in
neurons and tg mice expressing a human mutant gene
that causes motor neuron disease [28-30]. We thus gen-
erated double tg with Thy1-mitoDsRed and human
mutant SOD1. Motor neuron mitochondria are known
to undergo mPTP-dependent pathological swelling and
fragmentation in these G93A-SOD1 mice [29,30], and
this mitochondrial pathobiology was observed and
Figure 5 Further characterization of the intracellular
localization of DsRed in neurons Thy1-mitoDsRed2 tg mice.
Immunofluorescent localization of catalase (A), LC3A (B) and
cytochrome P450 reductase (C), as markers for peroxisomes/nucleus,
autophagic vesicles and endoplasmic reticulum (ER), respectively, in
brainstem sections shows mitochondrial-specific labeling with
DsRed. Cell nuclei (blue) were visualized with the DNA stain
Hoechst-33342 dye. A. Large brainstem neurons showing
intracellular segregation of catalase immunoreactivity (green) and
DsRed. Scale bar = 7 μm. B. Brainstem neurons showing partial
overlap of cytoplasmic DsRed and LC3A (green) seen as yellow.
Individual red and green signals are also seen. Scale bar = 5 μm. C.
Brainstem locus ceruleus neurons (red, right) peri-cerulean neurons
showing distinct DsRed and ER (green) intracellular localizations.
Scale bar = 5 μm. Images are representative of several different tg
mice (n = 8).
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Page 7 of 15Figure 6 Thy1-mitoDsRed2 tg mice in studies of motor neurons. A. E13 tg Hb9-eGFP mouse embryo section showing motor neurons below
the sulcus limitans (SL). Scale bar = 40 μm. B. Spinal cords of E13 Hb9-eGFP tg mouse embryos were subjected to flow cytometry and sorted by
side scatter (SSC) and forward scatter (FSC) into small cells/debris and large cells (P1, blue and red dots). C. P1 (large) cells were subjected to
FACS and sorted by viability based on phycoerythrin annexin (PE-A) negativity and eGFP (FITC)-positivity resulting in P2 cells. D. Cultured P2 cells
were eGFP-positive motor neurons. Scale bar = 15 μm. E, F. Mitochondria (F, arrows) in living Hb9-eGFP motor neurons visualized by
transfection with Thy1-mitoDsRed2 construct. Scale bar = 7 μm. G, H. Double tg mice expressing Hb9-eGFP and Thy1-mitoDsRed2 were created
to image mitochondria (arrows) directly in living motor neurons. Scale bar = 7 μm. I, J. Mitochondrial visualization (hatched arrows) in situ in
spinal cord motor neurons of Thy1-mitoDsRed tg mice (I) and tg ALS mice expressing human mutant SOD1 and Thy1-mitoDsRed (J). Asterisks
mark nucleus. MitoDsRed reveals directly the mitochondrial swelling (J, hatched arrows) and fragmentation (J, open arrow) in ALS mouse motor
neurons, and magnitude of mitochondrial swelling (K). Scale bars = 2 μm (I) and 2.5 μm (J). K. Mitochondrial diameters in motor neurons of
Thy1-mitoDsRed2 tg mice (control) and SOD1-G93A:Thy1-mitoDsRed2 tg mice. Values are mean ± SD. Mitochondrial diameters in motor neurons
were increased 5-fold (*, p < 0.01, n = 6 mice/group).
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mitoDsRed:G93A-SOD1 mice (Figure 6I-K). DsRed-
tagged mitochondria in motor neurons of G93A-SOD1
mice showed evidence for both swelling and fragmenta-
tion (Figure 6J). Some aberrant motor neuron mitochon-
dria exceeded 3 μm in diameter in these mutant mice
(Figure 6K).
To further demonstrate the utility of Thy1-mitoDsRed
tg mice, and to reveal novel aspects of mitochondrial
biology in stressed neurons, we used an in vivo excito-
toxicity paradigm (Figure 7). We made stereotaxic
microinjections of kainic acid (KA), a potent non-
NMDA glutamate agonist [16], into the lumbar spinal
cord ventral horn of Thy1-mitoDsRed tg mice and
tracked changes in mitochondrial morphology in puta-
tive motor neurons in spinal cord sections at different
times post-injury. Motor neurons in spinal cords
injected with vehicle showed a perikaryal distribution of
relatively uniform round, ellipsoid, and vermiform mito-
chondria (Figure 7A). In contrast, motor neurons under-
going excitotoxic injury had numerous perinuclear
mitochondria appearing to undergo fragmentation or
fission within 6-12 hours (Figure 7B). At about 12 hours
later, perinuclear mitochondria in motor neurons
appeared swollen, clumped, or aggregated (Figure 7C),
findings similar to those seen in mutant SOD1 tg mice
(Figure 6J, K) [30]. To help interpret the morphological
findings, western blotting was done for dynamin-related
protein 1 (Drp1), a mitochondrial fission protein [31].
The temporal pattern seen for Drp1 in lumbar spinal
cord extracts was an upregulation of Drp1 levels at 12 h
postlesion, followed by a loss of Drp1 immunoreactivity
at 24 postlesion (Figure 7D). The early upregulation of
Drp1 is consistent with excitotoxicity-induced mito-
chondrial fission in motor neurons [16].
Discussion
We have created new tg mice to study specifically neu-
ronal mitochondria. The construct that we engineered
included a DsRed2 gene variant with low aggregation
properties [32], a Thy1 promoter for neuron-specific
expression [33], and a cytochrome c oxidase subunit
VIII mitochondrial-specific targeting sequence [34].
These tg mice have mitochondria labeled with DsRed in
neurons throughout the CNS.
Before going to the expense of zygote microinjection
for mouse transgenesis, we ensured that the expression
construct worked in cell culture experiments. Thy1-
mitoDsRed plasmid DNA was transfected into primary
neurons and immortalized neurons and they showed
robust DsRed-tagging of mitochondria in live cell cul-
ture. Our gold standard comparator for DsRed-labeled
mitochondria was the original commercial mito-DsRed
expression plasmid used for cloning. The patterns of
Figure 7 Application of Thy1-mitoDsRed tg mice in studies of
kainic acid (KA) excitotoxicity-induced mitochondrial fission in
spinal cord motor neurons. A. Mice with phosphate-buffered
saline (PBS) injections placed stereotaxically in lumbar spinal cord
had motor neurons with perikaryal (asterisk identifies the nucleus of
individual neurons in all images in A-C) DsRed-tagged mitochondria
having normal mostly uniform appearances and distributions. B.
Mice with KA injections in lumbar spinal cord and 12-hour recovery
had motor neurons with perikaryal DsRed-tagged mitochondria
appearing heterogeneous in size with an apparent increase in small
round mitochondria. C. Mice with KA injections in lumbar spinal
cord and 24-hour recovery had motor neurons with perikaryal
DsRed-tagged mitochondria appearing as swollen, clumped or
aggregated. Scale bar (in A) = 5 μm (same for B and C). Images are
representative of four different tg mice per group. D. Western blot
for Drp1 in lumbar spinal cord extracts of Thy1-mitoDsRed tg mice
after intraspinal injection of PBS or KA and survival for 12 or 24
hours. Actin is shown for protein loading.
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mid, except that no astrocyte expression of DsRed was
observed with the Thy1-mitoDsRed construct. The
observations on mitochondrial distribution and mor-
phology in cultured neural cells gleaned from using our
Thy1-mitoDsRed construct are consistent with the lit-
erature on neural cell mitochondria [23,24,35]. Further
support for the mitochondrial localization of DsRed in
neurons in culture was derived from the anticipated
pathological changes seen with mitochondria (e.g., swel-
ling and rounding) when neurons received an excito-
toxic challenge. Therefore our construct was engineered
properly and worked effectively.
The tg mice developed using this construct showed
brain- and spinal cord-specific expression of DsRed in
mitochondria as determined by western blotting, RT-
PCR (except for 1 of 5 mouse lines that showed limited
kidney expression), and immunofluoresence for subcel-
lular markers. However, some peripheral organ expres-
sion could be due to DsRed in mitochondria of
peripheral nerves, but this is seemingly below the limit
of protein detection in crude tissue extracts. Subcellular
fractionation of CNS tissues confirmed that the DsRed
was found the mitochondrial-enriched fractions. The
mRNA expression profiles for the DsRed gene further
confirmed the CNS-specific expression of mitoDsRed. In
tissue sections of brain and spinal from tg mice, mito-
chondrial fluorescence was observed in subsets of neu-
rons. DsRed fluorescent structures in the cell bodies and
processes of neurons colocalized with immunodetected
mitochondrial markers, and were not found in the
nucleus, peroxisomes, or ER. Thus, the creation of tg
mice with neuron-specific DsRed-tagged mitochondria
was successful. Interestingly, not all mitochondria within
an individual neuron were tagged with DsRed, suggest-
ing that the pool of mitochondria within a single neuron
is heterogeneous. A within-cell mitochondrial heteroge-
neity in neurons has been suggested before [36]. We
also found that some DsRed-tagged mitochondria in
neurons co-labeled with the autophage marker LC3A.
Thus, our new tg mice might be useful also for tracking
mitophagy in neurons.
Three previous papers have described the generation
of tg mice expressing fluorescent proteins in the mito-
chondria of neurons [37-39]. In an elegant study, condi-
tional bigenic tg mice were created by generating tg
mice with a tetracycline responsive element driving
mitochondrial targeted enhanced YFP and crossing
them to tg mice with calcium/calmodulin-dependent
kinase IIa (CaMKIIa)-driven tetracycline transactivator
[37]. In histological preparations, these mice showed
YFP-tagged mitochondria in neurons of cerebral cortex
hippocampus, hippocampus and striatum [37]. Because
of the use of the CaMKIIa promoter, only subsets of
neurons in forebrain displayed mitochondrial fluorescent
protein, unlike our mice which have DsRed-tagged mito-
chondria in neurons throughout the CNS. This previous
study also made the important finding that mitochon-
dria isolated from these mice had normal bioenergetics
[37]. Another group created a tg mouse also using the
Thy1 promoter, but the mitochondrial-targeted fluores-
cent protein was cyan fluorescent protein [38] instead of
YFP or DsRed. The different tg mouse lines displayed
marvelous blue fluorescent mitochondria in distributions
throughout the CNS, much like our Thy1-mitoDsRed
mice, with the patterns in hippocampus and spinal cord
being very similar. More recently, tg mice expressing
mitochondrial-targeted eGFP were generated using a
CAG promoter driving expression throughout the body,
rather than being CNS-specific [39]. Interestingly, these
mice [38,39], as in ours, show intense fluorescent label-
ing in the neuropil. We predict the DsRed fluorescence
in the neuropil corresponds to mitochondria in distal
dendrites, spines, and presynaptic axon terminals, which
needs to be addressed using immunogold electron
microscopy using antibody to DsRed. However, before
such a task in undertaken, we need to better character-
i z et h eD s R e da n t i b o d yu s e dh e r ef o rs u i t a b i l i t yi n
immunohistochemical applications, or use different reli-
able antibodies to DsRed. In any event, Lichtman and
colleagues [38] addressed the issue of the non-somal
fluorescent protein-tagged mitochondria by using live
cell time-lapse imaging of peripheral nerve axons and
demonstrating magnificently the trafficking of mito-
chondria in axons.
We demonstrated how neurons with mitochondrial
targeted DsRed tg can be useful to the study of motor
neurons, and novel aspects of their mitochondrial biol-
ogy, in four different novel paradigms. In one experi-
ment, we used FACS to isolate spinal cord motor
neurons from Hb9-eGFP tg mouse embryos. Viable
eGFP-positive motor neurons were cultured and then
transfected with Thy1-mitoDsRed construct to visua-
lize mitochondria specifically in a relatively pure popu-
lation of motor neurons in cell culture. This idea was
pursued in a second experiment by crossing Hb9-eGFP
tg mice and Thy1-mitoDsRed tg mice. Primary
embryonic spinal cord cultures were prepared to visua-
lize eGFP/mitoDsRed dual-labeled motor neurons. In a
third experimental design, Thy1-mitoDsRed tg were
crossed to tg mice expressing human mutant SOD1.
Tg mice expressing human mutated SOD1 genes
develop fatal motor neuron disease [28] with severe
mitochondrial pathology as detected with biochemical
methods, antibodies to mitochondrial proteins, and
electron microscopy [29,30,40]. Double tg mice expres-
sing mutant SOD1 and mito-DsRed reveal directly the
mitochondriopathy in motor neurons without the aid
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Motor neurons in these ALS mice showed evidence for
severe mitochondrial swelling and fragmentation or
possible fission. Similar experiments are planned for
crossing Thy1-mitoDsRed tg mice to mouse models of
Parkinson’s disease [41] and Alzheimer’sd i s e a s e[ 4 2 ]
to further pursue mitochondrial-based mechanisms of
disease.
Thy1-mitoDsRed tg mice were used in a fourth
experimental application involving spinal cord excito-
toxic injury. We have reported previously that excito-
toxic activation of glutamate receptors on spinal cord
motor neurons in vivo induces rapid fragmentation or
fission of mitochondria mediated by activation of the
mPTP [16]. Our experiments here confirm and extend
this finding by visualizing these mitochondrial morphol-
ogy changes directly and showing that the abnormality
is associated with an upregulation of Drp1. This latter
result suggests that excitotoxicity in vivo acutely induces
mitochondrial fission in motor neurons. However, as the
injury evolves mitochondria may undergo fusion to form
large abnormal aggregates or clusters of mitochondria
within the perikaryon of motor neurons.
Conclusions
This is the first demonstration of the generation of a tg
mouse with DsRed protein expressed selectively in mito-
chondria of neurons throughout the CNS. We describe
the development and biochemical and histological char-
acterization of these mice. This new tg mouse has broad
application for studies of neuronal mitochondrial biol-
ogy and the involvement of neuronal mitochondria in
the cellular and molecular mechanisms of neurodegen-
eration in mouse and cell models of neurological dis-
ease. The applications of these new tg mice provide
novel insights into the pathobiology of mitochondria in
neurons, such as their swelling and fission, and are rele-
vant to ALS.
Methods
Design of Thy1-mitoDsRed gene construct
We used a Thy-1 promoter (generously provided by Dr.
Pico Caroni) to drive DsRed2 expression in a neuron-
specific pattern [33]. This promoter has been used to
create several lines of tg mice with neuron-specific
expression of exogenous proteins [43,44]. The Thy1 reg-
ulatory element for expression is composed of a 4.1 kb
fragment obtained from the 5’ portion of the Thy1 gene
extending from the promoter to the intron following
exon 4, but exon 3 and its flanking introns are absent
[33]. These sequence deletions are responsible for neu-
ron-specific expression and the absence of expression in
non-neural cells. DsRed2 is a genetic variant of DsRed
modified with six point mutations (Clontech
Laboratories, Mountain View, CA). These mutations
improve the solubility of DsRed2 by reducing its ten-
dency to form aggregates [32]. DsRed2 retains the bene-
fits typical of red fluorescent proteins, such as low or no
autofluorescence and high signal-to-noise ratio, and is
optimized for compatible expression in mammalian cells
as a reporter gene [32]. The vector used was pDsRed2-
mito (Clontech). This vector encodes the full-length
Dicosoma sp. red fluorescent protein and the mitochon-
drial targeting sequence from subunit VIII of human
cytochrome c oxidase [34]. The mitochondrial targeting
sequence was ligated in frame to the 5’ end of the
DsRed2 gene to direct the protein expression of DsRed2
only in the mitochondria of cells.
Neuronal cell culture and transfection
The NSC34 cell line was obtained from Cellutions Bio-
systems Inc (Ontario, Canada). NSC34 cells are a mouse
spinal cord cell line created by fusing embryonic pri-
mary spinal cord cells with neuroblastoma cells [45].
Under appropriate culture conditions NSC34 cells can
differentiate into motor neuron-like cells [46]. NSC34
cells were maintained and subcultured every 3 days in
DMEM with 10% fetal bovine serum. NSC34 cell differ-
entiation culture medium consisted of high-glucose
DMEM supplemented with 10% heat-inactivated fetal
bovine serum (Invitrogen, Carlsbad, CA), 2 mM L-gluta-
mine, 0.1 mM nonessential amino acids, and antibiotics
at 37°C in 95% air-5% CO2. NSC34 cells used for trans-
fection experiments were cultured between 5-10 days in
vitro (DIV).
All protocols (MO10321) using animals were approved
by the Animal Use and Care Committee of the Johns
Hopkins University School of Medicine. Primary
embryonic motor neuron and cortical neuron cultures
were prepared from timed-pregnant tg mice (B6.Cg-Tg
(Hlxb9-gfp)1Tmj/j) expressing eGFP driven by the
mouse Hlxb9 (Hb9) promoter [17] obtained from The
Jackson Laboratory (Bar Harbor, Maine) and from
Thy1-mitoDsRed2 tg mice (see below for generation).
Hb9 is a homeodomain transcription factor that is
expressed by motor neurons and functions during devel-
opment to consolidate motor neuron identity [47,48].
To obtain embryos for dissociated spinal cord neuron
and cortical neuron culture, gestational day 12-14 (E12-
14), female mice with potential tg Hb9-eGFP or Thy1-
mitoDsRed2 embryos were anesthetized with isoflurane
and all embryos were harvested by caesarian section.
Hb9-eGFP expression in embryos was confirmed under
a fluorescence microscope. Primary motor neuron cul-
tures were obtained from total spinal cords of male and
female Hb9-eGFP
+ embryos. Primary cortical neuron
cultures were obtained from total cerebral cortices of
male and female embryos irrespective of eGFP or DsRed
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w e r ed i s s e c t e da n di n c u b a t e df o r3 0m i ni n0 .0 2 5 %
trypsin and then dissociated by gentle trituration. Tryp-
sin-digested spinal cords were washed in HBSS and
sorted by fluorescence-activated cell sorting (FACS)
using a FACSVantage SE flow cytometer equipped with
an Argon laser for excitation at 488 nm. The resulting
pure motor neurons or mixed cortical cells were plated
on poly-D-lysine/laminin-coated glass coverslips (12 mm
in diameter; BD Transduction Laboratories, Franklin
Lakes, NJ) or chamber slides and maintained in Dulbec-
co’s modified Eagle’s medium (DMEM) supplemented
with 5% fetal bovine serum and 5% horse serum (Invi-
trogen). At 4-6 h after plating, the medium was replaced
with Neurobasal supplemented with B-27 (Invitrogen)
or with DMEM supplemented with 10% horse serum.
On the second day after plating, uridine and 5-fluoro-2-
deoxyuridine were added to the culture medium to inhi-
bit the proliferation of contaminating non-neuronal
cells. The motor neurons and cortical neurons were
used for transfection or excitotoxicity experiments on
DIV12-16.
Transient transfections of NSC34 cells and primary
motor neuron and cortical neurons with Thy1-
mitoDsRed2 expression plasmids were performed using
Lipofectamine 2000 (Invitrogen). As a positive control
NSC34 cells and primary neurons were transfected with
the original mitoDsRed2 plasmid with a CMV promoter
(Clontech) which was used to engineer our construct.
Live cells were imaged using epifluorescence microscopy
48 h later and were then fixed for 20 min in 4% parafor-
maldehyde/4% sucrose.
Thy1-mitoDsRed cortical neurons grown in DMEM
and horse serum were subjected to excitotoxic stress by
adding the highly-specific N-methyl-D-aspartate gluta-
mate receptor agonist quinolinic acid to the media at a
final concentration of 100 μM. Live cells were imaged
using epifluorescence microscopy 4-24 h later.
Generation of Thy1-mitoDsRed2 tg mice
To create tg mice, pUC18 plasmid was restriction
enzyme digested, resulting in a 7.1 Kb fragment. The
fragments were given to the Johns Hopkins Trans-
genic Core Facility for zygote-injection-based trans-
genesis using B6SJLF1 mouse embryos. The
institutional Animal Care and Use Committee
approved the animal protocols. Potential founders
were screened by PCR analysis of tail genomic DNA
using 3 different primer pairs. Mouse tails were
digested using DirectPCR Lysis Reagent (Viagen Bio-
tech, Los Angeles, CA) and DNA was extracted from
the lysate by precipitation with isopropanol. The pre-
sence of the mito-DsRed transgene was identified with
the following sets of primers:
5’-GACCCACAAGGCCCTGAAG-3’ and 5’-
TGCTCCACGATGGTGTAGTCC-3’ (product 719 bp);
5’-ATGGCCTCCTCCGAGAACGTCATC-3’ and 5’-
GGTACCGTCGACTGCAGAATTCGA-3’ (product 715
bp); 5’- GTTCCAGTACGGCTCCAAGGTGTA-3’ and
5’-ATGGTGTTAGTCCTCGTTGTGGGAG-3’ (product
438 bp); or 5’-CCCCGTAATGCAGAAGAAGA-3’ and
5’-GGTGATGTCCAGTTGGAGT-3’ (product 208 bp).
All PCR products contained a coding region of DsRed2
gene. For an internal control the interleukin-2 gene was
amplified with the following primers: 5’-CTAGGCCA-
CAGAATTGAAAGATCT-3’ and 5’-GTAGGTG-
GAAATTCTAGCATCATCC-3’ (product 324 bp).
PCR was performed using a Techne thermocycler with
a 2 min preheating at 95°C, followed by 35 cycles of
denaturation at 95°C, 1 min, annealing at 55°C, 1 min
and extension at 72°C, 1 min. Amplification was com-
pleted with an additional 7 min extension at 72°C. PCR
products were resolve by agarose gel electrophoresis and
stained with ethidium bromide.
Tissue harvesting for protein and mRNA expression
Thy1-mitoDsRed2 tg and non-tg mice at 2-4 months of
age (n = 4-6/genotype) and 10-12 months of age (n = 4-6/
genotype) were killed by CO2 inhalation, and the following
tissues and organs were quickly harvested and frozen on
dry ice: brain, spinal cord, hindleg skeletal muscle, liver,
kidney, and heart. Before freezing some brains were also
microdissected in ice-cold media into the following
regions: olfactory bulb, cerebral cortex, hippocampus,
striatum, diencephalon, brainstem, and cerebellum.
Immunoblotting
Western blot analysis was performed to examine expres-
sion of DsRed in CNS and systemic organs. Tissue sam-
ples were pulverized and homogenized with a Brinkmann
polytron in ice-cold 20 mM Tris HCl (pH 7.4) containing
10% (wt/vol) sucrose, 200 mM mannitol, complete pro-
tease inhibitor cocktail (Roche, Indianapolis, IN), 0.1 mM
phenylmethylsulfonyl fluoride, 10 mM benzamidine, 1
mM EDTA, and 5 mM EGTA. Crude homogenates were
sonicated for 15 sec and then centrifuged at 1, 000 gav for
10 min (4°C). The supernatant was centrifuged at 54, 000
gav for 20 minutes (4°C) to yield soluble (S2) and mito-
chondria-enriched pellet (P2) fractions. This subcellular
fractionation protocol has been verified [49]. The pellet
fraction was washed (twice) by trituration in homogeniza-
tion buffer followed by centrifugation and then finally
resuspended in homogenization buffer (without sucrose)
supplemented with 20% (wt/vol) glycerol. Protein concen-
trations were measured by a Bio-Rad protein assay with
bovine serum albumin as a standard.
Tissue protein extracts from Thy1-mitoDsRed2 tg
mice and non-tg mice were subjected to sodium dodecyl
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and transferred to nitrocellulose membrane by electroe-
lution as described [49]. Recombinant DsRed protein
(Clontech) was loaded as a positive control. The reliabil-
ity of sample loading and electroblotting in each experi-
ment was evaluated by staining nitrocellulose
membranes with Ponceau S before immunoblotting.
Ponceau S stained membranes were scanned for docu-
mentation of protein loading and even transfer among
lanes. If transfer was not uniform, blots were discarded
and gels were run again. Blots were blocked with 2.5%
n o n f a td r ym i l kw i t h0 . 1 %T w e e n2 0i n5 0m MT r i s -
buffered saline (pH 7.4), then incubated overnight at 4°
C with antibodies to DsRed that were either rabbit poly-
clonal antibodies (BioVision Research Products, Moun-
tain View, CA) or mouse monoclonal antibody
(Clontech). The antibodies were used at concentrations
for visualizing protein immunoreactivity within the lin-
ear range. As a protein loading control, some blots were
re-probed with monoclonal antibody to cofilin (Sigma-
Aldrich, St Louis, MO). After the primary antibody
incubation, blots were washed and incubated with
horseradish peroxidase (HRP)-conjugated secondary
antibody (0.2 μg/ml), developed with enhanced chemilu-
minescence (Pierce), and exposed to x-ray film.
Reverse transcription-polymerase chain reaction (RT-PCR)
To corroborate findings based on DsRed antibody
approaches, RT-PCR was used to analyze mRNA expres-
sion for DsRed in Thy1-mitoDsRed tg mice. Total RNA
was extracted using TRIzol (Invitrogen) from mouse CNS
and peripheral organs. cDNA synthesis was accomplished
using SuperScript One-Step RT-PCR with Platinum Taq
(Invitrogen) followed by PCR. The oligonucleotide primer
pair used to amplify a DsRed cDNA 435 bp product was:
sense, 5’-CTGTCCCCCCAGTTCCAGTAC-3; antisense,
5’-cgttgtgggaggtgatgtccagct-3’ [50]. For a total RNA con-
trol for each sample, oligonucleotide primers for mouse
voltage-dependent anion channel-1 (VDAC1) were 5’-
GCTAAGGATGACTCGGCTTTAAGG-3’ and 5’-AGGT-
TAAGTGATGGGCTAGGATGG-3’ which give a 335 bp
amplification product [51]. The PCR products were sepa-
rated on a 1.0% agarose gel stained with ethidium bromide
and imaged using a BioRad molecular imaging VersaDoc
system.
Histology and immunohistochemistry
Thy1-mitoDsRed tg mice and age-match non-tg litter-
mate control mice at 1 month, 6 months and 12 months
of age(n = 6-10/genotype/time) were deeply anesthetized
and perfusion-fixed using 4% paraformaldehyde. After
perfusion-fixation, the brain and spinal cord were
removed from each mouse, and the tissues were cryo-
protected (20% glycerol). The brains and lumbar spinal
cords were frozen-sectioned (40 μm) in the transverse
plane using a sliding microtome. Serial section arrays
were stored individually in 96-well plates. Every 10
th
section of brain and spinal cord was mounted on glass
slides, coverslipped with antifade mounting medium,
and viewed using epifluorescence or confocal
microscopy.
To characterize the intracellular localization of DsRed
in tg mice known markers for organelles were used for
dual labeling. The mitochondrial outer membrane vol-
tage-dependent anion channel (VDAC) was detected
with a mouse monoclonal antibody (MitoScience,
Eugene, OR) diluted at 1:500. The mitochondrial matrix
protein manganese superoxide dismutase (MnSOD,
SOD2) was detected with two different rabbit polyclonal
antibodies (SOD-110 and SOD-111, Stressgen, Victoria,
B r i t i s hC o l u m b i a ,C a n a d a )d i l u t e da t1 : 5 0 0 .T h ep e r o x i -
some and nuclear compartments were visualized with a
sheep polyclonal antibody to catalase (Biodesign interna-
tional, Saco, ME) diluted at 1:500. The ER compartment
was visualized with a rabbit polyclonal antibody to cyto-
chrome P450 reductase (Stressgen) diluted at 1:500.
Immunoreactivities were visualized with an AlexaFluor-
488 conjugated secondary antibody and counterstained
with Hoechst-33342 dye for nuclear identification.
To determine if DsRed2 expression caused neurotoxi-
city in tg mice, brain and spinal cord sections were also
examined for pathology. Sections were examined using
Nissl staining with cresyl violet, silver staining using the
FD NeuroSilver kit (FD Neurotechnologies Inc, Balti-
more, MD), and immunofluorescent staining for cleaved
caspase-3 detected with a rabbit polyclonal antibody
(1:1000) to the active subunits (Cell Signaling, Beverly,
MA) and AlexaFluor-488 conjugated secondary
antibody.
Double tg mice
Two different lines of tg mice were crossed to Thy1-
mitoDsRed tg mice. To study mitochondria in specifi-
cally motor neurons, Thy1-mitoDsRed tg mice were
crossed to Hb9-eGFP tg mice. To study mitochondria in
a mouse model of ALS, Thy1-mitoDsRed tg mice were
crossed to human G93A-mutant SOD1 tg mice [29,30].
F1 offspring positive for the DsRed and eGFP transgenes
or DsRed and human SOD1 transgenes were identified
by PCR. Histology was done as described above. Mito-
chondrial diameter measurements in motor neurons
were done as described [29]. Small-particle, mitochon-
drial fragment-like structures were not measured due to
resolution limits.
Excitotoxic lesions in mouse spinal cord
Adult Thy1-mitoDsRed tg mice were anesthetized dee-
ply with isoflurane (4%) in O2 in an induction chamber,
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betadine and 70% isopropyl alcohol. Mice were mounted
in a stereotaxic apparatus (Stoelting, Wood Dale, IL)
with a customized vertebral column stabilizer. Surgical
anesthesia was maintained with isoflurane (2%), nitrous
oxide (66%), and O2 (32%) delivered by a nosepiece
mask. Body temperature was maintained with external
warming. A midsagittal incision (4 mm) was made over
the lumbar back, and the dorsal part of the L1-L3 ver-
tebral column was carefully freed of attached fascia and
skeletal muscle. After a laminectomy at L2, performed
slowly and carefully without traumatizing the spinal
cord and causing any edema, a stereotaxic injection of
the non-NMDA ion channel glutamate receptor agonist
kainic acid (KA, 400 μmol, 1 μl volume) was made uni-
laterally directly into the parenchyma of lumbar spinal
cord using a mounted 10-μl Hamilton syringe and a
sharp, stainless steel needle (26 gauge) with a 45° bev-
eled angle. KA (Sigma) was dissolved in 100 mM phos-
phate-buffered saline (PBS, pH 7.4) and was stored in
the dark at -20°C until used. The dose of KA was estab-
lished previously [16]. Mice injected unilaterally with
100 mM PBS (1 μl) were controls. Injections were per-
formed manually. To prevent leakage from the injection
site, neurotoxin and buffer were injected over 1 min,
and the needle was left in place for 3 min before it was
withdrawn slowly. The laminectomy was sealed with sof-
tened W-31 bone wax (Ethicon, Somerville, NJ), and the
wound was closed with a skin clip. Postoperative care
was as described [16].
At 6, 12, and 24 hours after the excitotoxic injection,
mice (n = 4/time) were deeply anesthetized with an
overdose of sodium pentobarbital and either perfused
intra-cardially with ice-cold PBS (100 mM, pH 7.4) fol-
lowed by ice-cold 4% paraformaldehyde in PBS or were
killed for harvesting of fresh unfixed spinal cord. After
perfusion-fixation, spinal cords remained in situ for 2
hours before they were removed by dorsal laminectomy
from the vertebral column. The lumbar enlargements
were cryoprotected in 20% glycerol-PBS, and frozen
under pulverized dry ice. Transverse cryosections (40
μm) were cut using a sliding microtome, mounted on
glass slides, and viewed using epifluorescence micro-
scopy. Fresh lumbar spinal cord samples were homoge-
nized and used for western blotting as described above.
Blots were probed for Drp1 using a rabbit polyclonal
antibody (ProteinTech Group,C h i c a g o ,I L )d i l u t e da t
1:800, then for actin as a loading control.
Photography and figure construction
The original images used for figure construction were
generated using digital photography. Digital images were
captured as TiFF files using a SPOT digital camera and
SPOT Advanced software (Diagnostic Instruments) or a
Nikon digital camera (DXM1200) and ACT-1 software.
Images were altered slightly for brightness and contrast
using ArcSoft PhotoStudio 2000 or Adobe Photoshop
software without changing the content and actual result.
Figure composition was done using CorelDraw 9 soft-
ware with final figures being converted to TiFF files.
Files of composite figures were adjusted for brightness
and contrast in Adobe Photoshop.
Acknowledgements
We express our gratitude to Dr. Pico Caroni for providing the Thy1
promoter. This work was supported by National Institutes of Health/National
Institute of Neurological Disorders and Stroke (R01-NS034100, R01-NS052098,
andR01-NS065895) and the National Institutes of Health/National Institute for
Aging (R01-AG016282).
Authors’ contributions
YW and LJM conceived and designed the experiments. YW made the
construct. LJM wrote the manuscript. YP and AP contributed to the
biochemical and histological characterization of the transgenic mice. All
authors approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 27 June 2011 Accepted: 2 November 2011
Published: 2 November 2011
References
1. Zuchner S, Meriyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J,
Dadali EL, Zappia M, Nelis E, Patitucci A, Senderek J, et al: Mutation in the
mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth
neuropathy type 2A. Nat Gen 2004, 36:449-451.
2. Wallace DC: A mitochondrial paradigm of metabolic and degenerative
diseases, aging, and cancer: a dawn of evolutionary medicine. Annu Rev
Genet 2005, 39:359-407.
3. Su B, Wang X, Zheng L, Perry G, Smith MA, Zhu X: Abnormal
mitochondrial dynamics and neurodegenerative diseases. Biochim Biophy
Acta 2010, 1802:135-142.
4. Reddy PH, Beal MF: Amyloid beta, mitochondrial dysfunction and
synaptic damage: implications for cognitive decline in aging and
Alzheimer’s disease. Trends Mol Med 2008, 14:45-53.
5. Smith MA, Perry G: Free radical damage, iron, and Alzheimer’s disease. J
Neurol Sci 1995, 134(Suppl):92-94.
6. Martin LJ: Mitochondrial and cell death mechanisms in
neurodegenerative diseases. Pharmaceuticals 2010, 3:839-915.
7. Hirsch T, Marchetti P, Susin SA, Dallaporta B, Zamzami N, Marzo I,
Geuskens M, Kroemer G: The apoptosis-necrosis paradox. Apoptogenic
proteases activated after mitochondrial permeability transition
determine the mode of cell death. Oncogene 1997, 15:1573-1581.
8. Zorov DB, Isave NK, Plotnikov EY, Zorova LD, Stelmashook EV, Vasileva AK,
Arkhagelskaya AA, Khrjapenkova TG: The mitochondrion as Janus Bifrons.
Biochemistry (Moscow) 2007, 72:1115-1126.
9. Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I,
Bernasconi L, Bernard A, Mermod J-J, Mazzei G, Maundrell K, Gambale F,
Sadoul R, Martinou J-C: Inhibition of bax channel-forming activity by bcl-
2. Science 1997, 277:370-372.
10. Marzo I, Brenner C, Zamzami N, Jürgensmeier JM, Susin SA, Vieira HL,
Prévost MC, Xie Z, Matsuyama S, Reed JC, Kroemer G: Bax and adenine
nucleotide translocator cooperate in the mitochondrial control of
apoptosis. Science 1998, 281:2027-2031.
11. Shimizu S, Ide T, Yanagida T, Tsujimoto Y: Electrophysiological study of a
novel large pore formed by Bax and the voltage-dependent anion
channel that is permeable to cytochrome c. J Biol Chem 2000,
275:12321-12325.
Wang et al. Molecular Neurodegeneration 2011, 6:75
http://www.molecularneurodegeneration.com/content/6/1/75
Page 14 of 1512. Martin LJ, Adams NA, Pan Y, Price A, Wong M: The mitochondrial
permeability transition pore regulates nitric oxide-mediated apoptosis of
neurons induced by target deprivation. J Neurosci 2011, 31:359-370.
13. Olenych SG, Claxton NS, Ottenberg GK, Davidson MW: The fluorescent
protein color palette. Cur Protoc Cell Biol 2007, 21.5:1-34.
14. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y: ’Green mice’ as
a source of ubiquitous green cells. FEBS Lett 1997, 407:313-9.
15. Atkin SD, Patel S, Kocharyan A, Holtzclaw LA, Weerth SH, Schram V, Pickel J,
Russell JT: Transgenic mice expressing a cameleon fluorescent Ca
2+
indicator in astrocytes and Schwann cells allow for study of glial cell Ca
2
+ signals in situ and in vivo. J Neurosci Meth 2009, 181:212-226.
16. Martin LJ: An approach to experimental synaptic pathology using green
fluorescent protein-transgenic mice and gene knockout mice to show
mitochondrial permeability transition pore-driven excitotoxicity in
interneurons and motoneurons. Toxicol Pathol 2011, 39:220-233.
17. Wichterle H, Lieberam I, Porter JA, Jessell TM: Directed differentiation of
embryonic stem cells into motor neurons. Cell 2002, 110:385-97.
18. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M,
nerbonne JM, Lichtman JW, Sanes JR: Imaging neuronal subsets in
transgenic mice expressing multiple spectral variants of GFP. Neuron
2000, 28:41-51.
19. Martin LJ, Liu Z: Adult olfactory bulb neural neural precursor cell grafts
provide temporary protection from motor neuron degeneration,
improve motor function, and extend survival in amyotrophic lateral
sclerosis mice. J Neuropathol Exp Neurol 2007, 66:1002-1018.
20. Oliva AA, Jiang M, Lam T, Smith KL, Swann JW: Novel hippocampal
interneuronal subtypes identified using transgenic mice that express
green fluorescent protein in GABAergic interneurons. J Neurosci 2000,
20:3354-68.
21. Zeilhofer HU, Studler B, Arabadzisz D, Schweizer C, Ahmadi S, Layh B,
Bosl MR, Fritschy J-M: Glycinergic neurons expressing enhanced green
fluorescent protein in bacterial artificial chromosome transgenic mice. J
Comp Neurol 2005, 482:123-41.
22. Jensen RE: Control of mitochondrial shape. Curr Opin Cell Biol 2005,
17:384-388.
23. Berman SB, Chen Y-b, Qi B, McCaffery JM, Rucker EB III, Goebbels S, Nave K-
A, Arnold BA, Jonas EA, Pineda FJ, Hardwick JM: Bcl-xL increases
mitochondrial fission, fusion, and biomass in neurons. J Cell Biol 2009,
184:707-719.
24. Reynolds IJ, Mlaiyandi LM, Coash M, Rintoul GL: Mitochondrial trafficking
in neurons: a key variable in neurodegeneration? J Bioenerg Biomemb
2004, 36:283-286.
25. Anderson P, Bliss TVP, Skrede KK: Lamellar organization of hippocampal
excitatory pathways. Exp Brain Res 1971, 13:222-238.
26. Chang Q, Martin LJ: Glycine receptor channels in spinal motoneurons are
abnormal in a transgenic mouse model of amyotrophic lateral sclerosis.
J Neurosci 2011, 31:2815-2827.
27. Chang Q, Martin LJ: Motoneuron subtypes show specificity in glycine
receptor channel abnormalities in a transgenic mouse model of
amyotrophic lateral sclerosis. Channels 2011, 5:1-5.
28. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD,
Caliendo J, Hentati A, Kwon YW, Deng HX, et al: Motor neuron
degeneration in mice that express a human Cu, Zn superoxide
dismutase mutation. Science 1994, 264:1772-1775.
29. Martin LJ, Liu Z, Chen K, Price AC, Pan Y, Swaby JA, Golden WC: Motor
neuron degeneration in amyotrophic lateral sclerosis mutant superoxide
dismutase-1 transgenic mice: mechanisms of mitochondriopathy and
cell death. J Comp Neurol 2007, 500:20-46.
30. Martin LJ, Gertz B, Pan Y, Price AC, Molkentin JD, Chang Q: The
mitochondrial permeability transition pore in motor neurons:
involvement in the pathobiology of ALS mice. Exp Neurol 2009,
218:33-346.
31. Chen H, Chan DC: Emerging functions of mammalian mitochondrial
fusion and fission. Hum Mol Genet 2005, 14:R283-R289.
32. Strack RL, Strongin DE, Bhattacharyya D, Tao W, Berman A, Broxmeyer HE,
Keenan RJ, Glick BS: A noncytotoxic DsRed variant for whole-cell labeling.
Nat Methods 2008, 5:955-957.
33. Caroni P: Overexpression of growth-associated proteins in neurons of
adult transgenic mice. J Neurosci Meth 1997, 71:3-9.
34. Rizzuto R, Brini M, Pizzo P, Murgia M, Pozzan T: Chimeric green fluorescent
protein as a tool for visualizing subcellular organelles in living cells. Curr
Biol 1995, 5:635-642.
35. Wang X, Su B, Lee H-g, Li X, Perry G, Smith MA, Zhu X: Impaired balance
of mitochondrial fission and fusion in Alzheimer’s disease. J Neurosci
2009, 29:9090-9103.
36. Wong-Riley MTT: Cytochrome oxidase: an endogenous metabolic marker
for neuronal activity. Trends Neurosci 1989, 3:94-101.
37. Chandrasekaran K, Hazelton JL, Wang Y, Fiskum G, Kristian T: Neuron-
specific conditional expression of a mitochondrially targeted fluorescent
protein in mice. J Neurosci 2006, 26:13123-13127.
38. Misgeld T, Kerschensteiner M, Bareyre FM, Burgess RW, Lichtman JW:
Imaging axonal transport of mitochondria in vivo. Nat Meth 2007,
4:559-561.
39. Shitara H, Shimanuki M, Hayashi J-I, Yonekawa H: Global imaging of
mitochondrial morphology in tissues using transgenic mice expressing
mitochondrially targeted enhanced green fluorescent protein. Exp Anim
2010, 59:99-103.
40. Bendotti C, Calvaresi N, Chiveri L, Prelle A, Moggio M, Braga M, Silani V, De
Biasi S: Early vacuolization and mitochondrial damage in motor neurons
of FALS mice are not associated with apoptosis or with changes in
cytochrome oxidase histochemical reactivity. J Neurol Sci 2001, 191:25-33.
41. Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, Jenkins NA, Price DL,
Lee MK: Parkinson’s disease α-synuclein transgenic mice develop
neuronal mitochondrial degeneration and cell death. J Neurosci 2006,
26:41-50.
42. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR:
Co-expression of multiple transgenes in mouse CNS: a comparison of
strategies. Biomol Eng 2001, 17:157-165.
43. Lino MM, Schneider C, Caroni P: Accumulation of SOD1 mutants in
postnatal motoneurons does not cause motoneuron pathology or
motoneuron disease. J Neurosci 22:4825-4832, 202.
44. Laird FM, Farah MH, Ackerley S, Hoke A, Maragakis N, Rothstein JD, Griffin J,
Price DL, Martin LJ, Wong PC: Motor neuron disease occurring in a
mutant dynactin mouse model is characterized by defects in vesicular
trafficking. J Neurosci 2008, 28:1997-2005.
45. Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT,
Dahrouge S, Antel JP: Neuroblastoma × spinal cord (NSC) hybrid cell
lines resemble developing motor neurons. Dev Dyn 1992, 194:209-221.
46. Chestnut BA, Chang Q, Lesuisse C, Wong M, Martin LJ: Epigenetic
regulation of motor neuron cell death through DNA methylation. J
Neurosci 2011.
47. Arber S, Han B, Mendelsohn M, Smith M, Jessell TM, Sockanathan S:
Requirement for the homeobox gene Hb9 in the consolidation of motor
neuron identity. Neuron 1999, 23:659-674.
48. Thaler J, Harrison K, Sharma K, Lettieri K, Kehrl J, Pfaff SL: Active
suppression of interneuron programs within developing motor neurons
revealed by analysis of homeodomain factor HB9. Neuron 1999,
23:675-687.
49. Martin LJ, Price AC, McClendon KB, Al-Abdulla NA, Subramaniam JR,
Wong PC, Liu Z: Early events of target deprivation/axotomy-induced
neuronal apoptosis in vivo: oxidative stress, DNA damage, p53
phosphorylation and subcellular redistribution of death proteins. J
Neurochem 2003, 85:234-247.
50. Seitz G, Warmann SW, Fuchs J, Mau-Holzmann UA, Ruck P, Heitmann H,
Hoffman RM, Mahrt J, Muller GA, Wessels JT: Visualization of
xenotransplanted human rhabdomyosarcoma after transfection with red
fluorescent protein. J Ped Surg 2006, 41:1369-1376.
51. Chen K, Northington FJ, Martin LJ: Inducible nitric oxide synthase is
present in motor neuron mitochondria and Schwann cells and
contributes to disease mechanisms in ALS mice. Brain Struct Funct 2010,
214:219-234.
doi:10.1186/1750-1326-6-75
Cite this article as: Wang et al.: Generation and characterization of
transgenic mice expressing mitochondrial targeted red fluorescent
protein selectively in neurons: modeling mitochondriopathy in
excitotoxicity and amyotrophic lateral sclerosis. Molecular
Neurodegeneration 2011 6:75.
Wang et al. Molecular Neurodegeneration 2011, 6:75
http://www.molecularneurodegeneration.com/content/6/1/75
Page 15 of 15